CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 7 enrolled
Drug / intervention
Contralaterally Controlled Neuromuscular Electrical Stimulation +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02199795
NCT02199795N/ACompleted
CompareCT.gov

Functional Electrical Stimulation Mediated Neuroplasticity: Lower Extremity CCNMES in Stroke

MetroHealth Medical Center·interventional·Posted Jul 24, 2014·Updated Nov 8, 2017

In Brief

A clinical study evaluating Contralaterally Controlled Neuromuscular Electrical Stimulation and Cyclic Neuromuscular Electrical Stimulation for Stroke and 2 related conditions. Completed, enrolled 7 participants across 1 site.

Detailed Summary

This is a small pilot randomized controlled trial which will enroll both subacute (\<6 mos) and chronic (\>6 mos) stroke survivors with ankle dorsiflexion weakness. The subjects will be randomized to Contralaterally Controlled Neuromuscular Electrical Stimulation (CCNMES) versus control. The primary objective of this study is to compare the effect of 6-weeks of lower extremity CCNMES, applied in an anti-phase application, on motor impairment and functional mobility to a control group.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsStroke, Hemiparesis, Footdrop
CountriesUnited States
CollaboratorsEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Case Western Reserve University

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJul 24, 2014
Enrollment StartMay 1, 2014
Primary CompletionFeb 1, 2015
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 11.9 years ago

Interventions

Contralaterally Controlled Neuromuscular Electrical Stimulationdevice

Cyclic Neuromuscular Electrical Stimulationdevice